E3C: EPIC, EPILOG, EPISTENT, CAPTURE

      -Long Term Mortality Follow-Up: EPIC, EPILOG, EPISTENT, CAPTURE

Early ACS: Early Glycoprotein IIb/IIia Inhibition In Non–St-Segment Elevation Acute Coronary Syndromes

      -Early ACS Trial (ACC 2009)

EASY: Early Discharge After Transradial Stenting Of Coronary Arteries

      -A Randomized Trial of Same-Day Home Discharge and Abciximab Bolus-Only Compared to Overnight Hospitalization and Abciximab Bolus + Infusion after Trans-Radial Coronary Stenting: 12-Months Results of the EASY Trial by Dr. OF Bernard

ECLIPSE: The Evaluation of CLevidipine In the Perioperative Treatment of Hypertension Assessing Safety Events trial

      -Blood Pressure Control is an Independent Predictor of Short-term Mortality in Cardiac Surgery Patients: Analysis from the Three Randomized ECLIPSE Trials by Dr. Solomon Aronson

      -Clevidipine Phase III Studies: Perioperative Hypertension

      -Blood Pressure Control with Clevidipine Compared with Nitroglycerin, Sodium Nitroprusside, or Nicardipine in the Treatment of Peri-operative Hypertension: Results of the Three Randomized ECLIPSE Trials by Dr. Solomon Aronson

Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery

      -Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery: Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae? By Dr. Emmanouil I. Kapetanakis

Effect of Distal Embolisation on Myocardial Perfusion Reserve Following Percutaneous Coronary Intervention: A Quantitative MR Perfusion Study

      -Effect of Distal Embolisation on Myocardial Perfusion Reserve Following Percutaneous Coronary Intervention: A Quantitative MR Perfusion Study

ELITE II: Losartan Heart Failure Survival Study

      -Effects of Losartan Compared with Captopril on Mortality in Patients with Symptomatic Heart Failure: Randomized Trial by Dr. Bertram Pitt

EMERALD: Enhanced Myocardial Efficacy and Removal by Aspiration of Liberated Debris

      -The EMERALD Trial Diabetic Substudy

      -Enhanced Myocardial Efficacy and Removal by Aspiration of Liberated Debris by Dr. Gregg W. Stone (ACC 2004)

ENDEAVOR IV: Randomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease-4

      -Late-Breaking Clinical Trial Presentation by Dr. Martin B. Leon (TCT 2007)

      -Three-year Follow-up by Dr. Martin B. Leon (TCT 2009)

ENDEAVOR Safety: Pooled Analysis of Early and Late Safety of a Zotarolimus-Eluting Stent

      -Late-Breaking Clinical Trial Presentation by Dr. Laura Mauri (TCT 2007)

ENTIRE TIMI-23: Enoxaparin And Tnk-Tpa With Or Without Gp IIb/IIIa Inhibitor As Reperfusion Strategy In St Elevation MI

      -ENTIRE TIMI-23 Trial

EPHESUS: Eplerenone Post-Ami Heart Failure Efficacy And Survival Study

      -Eplerenone Post-AMI Heart Failure Efficacy and Survival Study (ACC 2003)

EPIC: Evaluation Of C7E3 For The Prevention Of Ischemic Complications

      -EPIC Bolus infusion vs. Infusion by the EPIC Investigators

      -Primary Endpoint and Results by the EPIC Investigators

EPIC-Norfolk: European Prospective Investigation of Cancer

      -Value of Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study by Dr. Karim El Harchaoui

EPILOG: Evaluation Of PTCA To Improve Long-Term Outcome By C7E3 Gp IIb/IIIa Receptor (Abciximab) Blockade

      -EPILOG Results by the EPILOG Investigators

EPISTENT: Evaluation Of Platelet IIb/IIIa Inhibitor For Stenting Trial

      -EPISTENT - 1 Year Follow-Up

ERASE: Effects Of Rhdl On Atherosclerosis–Safety And Efficacy

      -Efecto del reconstituido de la lipoproteina de alta densidad (rHDL) en Ateroesclerosis. Seguridad y Eficacia por el Dr. Jean-Claude Tardif (ACC 2007) Spanish

      -The ERASE Trial: Effect of rHDL on Atherosclerosis-Safety and Efficacy by Dr. Jean-Claude Tardif (ACC 2007)

ERICA: The Efficacy of Ranolazine in Chronic Angina

      -Trial Overview by Dr. Peter H. Stone et al

ESCAPE: Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness

      -ESCAPE-1: Pre-operative (2007); ESCAPE 2: Post-operative (2008) Clevidipine Phase III Studies: Perioperative Hypertension

ESSENCE: The Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events

      -Study Overview by Dr. Marc Cohen

      -Economic Substudy by Dr. Daniel B. Mark

ESSENTIAL: The Studies Of Oral Enoximone Therapy In Advanced Heart Failure

      -The Studies of Oral Enoximone Therapy in Advanced Heart Failure by Dr. Marco Metra (ESC 2005)

EUROPA: European Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease

      -European trial on reduction of cardiac events with perindopril in stable coronary artery disease (ESC 2003)

EuroSTAR II: European Cobalt Stent With Antiproliferative For Restenosis Trial

      -The European Randomized CoStar Trial: Cobalt-Chromium Paclitaxel-eluting Stent vs. identical BMS by Dr. Sigmund Silber

EVA-AMI: Eptifibatide Versus Abciximab in primary PCI for Acute ST elevation Myocardial Infarction

      -Eptifibatide Versus Abciximab in primary PCI for Acute ST elevation Myocardial Infarction - EVA-AMI Trial by Dr. Uwe Zeymer (AHA 2007)

EVEREST: Randomized Comparison UpstrEam Standard Dose Tirofiban VERsus DownstrEam High-doSe Tirofiban or Abciximab in High-risk ACS Treated With PCI

      -Effects on epicardial and tissue level reperfusion, and postprocedural biomarkers release by Dr. Leonardo Bolognese

      -Percutaneous Mitral Repair with the MitraClip Device for Functional Mitral Regurgitation: Acute Success, One year Durability and Reverse Remodeling in the Initial EVEREST Cohort by Dr. James Hermiller

EVET: Enoxaparin versus Tinzaparin in Non-ST-segment Elevation Acute Coronary Syndromes

      -Enoxaparin versus Tinzaparin in Non-ST-segment Elevation Acute Coronary Syndromes: The EVET Trial by Dr. LK Michalis

EXPIRA: Thrombectomy With Export Catheter In Infarct-Related Artery During Primary Percutaneous Coronary Intervention

      -Impact of Thromboaspiration during Primary PCI on Microvascular Damage and Infarct Size: Acute and Long term CE-MRI Evaluation by Dr. Gennaro Sardella (AHA 2007)

      -Impact of thrombectomy with EXPort catheter in Infarct Related Artery on procedural and clinical outcome in patients with AMI (EXPIRA Trial). A Prospective, Randomized Trial of Thromboaspiration during Primary Angioplasty in Acute Myocardial Infarction by Dr. Gennaro Sardella (TCT 2007)

      -Thrombus Aspiration During Primary Percutaneous Coronary Intervention Improves Myocardial Reperfusion and Reduces Infarct Size: The EXPIRA (Thrombectomy With Export Catheter in Infarct-Related Artery During Primary Percutaneous Coronary Intervention) Prospective, Randomized Trial by Dr. Gennaro Sardella

      -Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy by Dr. Gennaro Sardella (AHA 2008)

EXPORT: Prospective, Randomized Trials of Thromboaspiration During Primary Angioplasty in Acute Myocardial Infarction

      -EXPORT Study First Report by Dr. Bernard Chevalier (TCT 2007)

ExTRACT TIMI-25: Enoxaparin And Thrombolysis Reperfusion For Acute Myocardial Infarction

      -Trial Overview by Dr. Elliott Antman (ACC 2006)

PCI ExTRACT TIMI-25: PCI in Patients Receiving Enoxaparin or UFH Following Fibrinolytic Therapy for STEMI

      -Study Overview by Dr. C. Michael Gibson et al (AHA 2006)

Completed TIMI Trials

      -Primary Results

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs test